Heartburn And Gerd – Risks For Cancer

Heartburn and gastroesophageal reflux disease (GERD) occur when stomach acid repeatedly flows back into the esophagus, irritating its lining. While occasional reflux is common, chronic GERD represents ongoing acid exposure that can damage tissue over time. Persistent inflammation may lead to cellular changes within the esophagus that increase cancer risk. Many individuals underestimate GERD because symptoms can fluctuate or seem manageable with over-the-counter medications. However, symptom severity does not always correlate with the degree of underlying damage. The video emphasizes that untreated reflux is not benign. Recognizing GERD as a chronic disease is the first step toward prevention.

One of the most concerning complications of long-standing GERD is Barrett’s esophagus, a condition in which normal esophageal cells are replaced with abnormal tissue. Barrett’s esophagus significantly increases the risk of esophageal adenocarcinoma, a serious and often deadly cancer. Risk factors include duration of reflux symptoms, male sex, obesity, smoking, and family history. Importantly, many patients with Barrett’s esophagus have minimal or no reflux symptoms. This makes proactive evaluation critical in higher-risk individuals. The video highlights when endoscopy should be considered even if symptoms appear controlled. Early detection allows surveillance and intervention before cancer develops.

Management of heartburn and GERD focuses on reducing acid exposure and healing the esophagus. Lifestyle modifications such as weight loss, dietary changes, avoiding late meals, and elevating the head of the bed play a central role. Medications like proton pump inhibitors and H2 blockers reduce acid production and promote tissue healing. In selected cases, further testing or surgical intervention may be appropriate. Consistent treatment not only improves quality of life but also reduces long-term cancer risk. The key message is that chronic heartburn deserves medical attention, not dismissal.